Prognosis of apical hypertrophic cardiomyopathy in patients with an implantable cardioverter defibrillator

27 August 2021 (00:00 - 00:00)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Miyo Nakano

Chiba University Graduate School of Medicine, Chiba (Japan)

23 More presentations in this session

Presentation thumbnail

Left atrial dysfunction still exists in patients who obtain normal left atrial volume after successful ablation of atrial fibrillation.

Doctor H. Kawakami (Toon, JP)

Abstract Slides

Presentation thumbnail

Same day discharge after atrial fibrillation ablation is feasible and safe. Results of a prospective study in 1015 patients

Mr M. Viezelis (Odense, DK)

Abstract Slides

Presentation thumbnail

Benefits of early intervention with catheter ablation in patients with atrial fibrillation

Doctor S. Mohanty (Austin, US)

Abstract Slides

Presentation thumbnail

Cryoballoon ablation of atrial fibrillation in low and medium volume hospitals - experiences of the German REGIONAL registry

Doctor J. Michaelsen (Lingen, DE)

Abstract Slides

Presentation thumbnail

Accuracy comparison of the new and previous Kodex occlusion tool software versions to assess pulmonary vein occlusion in atrial fibrillation cryoablation

Doctor M. Polselli (Rome, IT)

Abstract Slides

Access the full session

Session thumbnail

Congress committee e-posters choice in arrhythmias and device therapy

The Event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

You may be interested in

Congress Presentation

Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy

Congress Session

Risk assessment and prevention of sudden cardiac death in cardiomyopathies

Congress Presentation

When to consider device therapy in HFrEF - discussion

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources